Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision tag on the page changed from v3.6.5 to v3.6.6. This indicates a minor page version update rather than changes to the study content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision number updated from v3.6.4 to v3.6.5, indicating a minor administrative update to the page. This does not appear to modify the study content or results.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3 tag; this reflects a minor site update rather than a change to the study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance patch to the study record page. No study data or user-facing content appears to have changed.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page revision tag was updated to v3.6.2, indicating a small version update. No substantive changes to study content are indicated.SummaryDifference0.1%

- Check87 days agoChange DetectedEnrollment status updated to indicate no longer recruiting; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision history updated to v3.6.0, reflecting a formatting change to the Intervention/Treatment heading.SummaryDifference0.6%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.